| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/15/2002 | WO2001032843A9 Enhanced immune recognition of pathogenic cells by icsbp expression |
| 08/15/2002 | WO2001019856A3 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111475 Flt3-L mutants and methods of use |
| 08/15/2002 | US20020111470 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 08/15/2002 | US20020111469 Polypeptide for use in the treatment of tumors, lung defects, inflammation and heart defects |
| 08/15/2002 | US20020111467 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/15/2002 | US20020111325 VEGI, an inhibitor of angiogenesis and tumor growth |
| 08/15/2002 | US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors |
| 08/15/2002 | US20020111323 Genetic engineering |
| 08/15/2002 | US20020111303 Protein found in breast, prostate gland cells cancer membrane |
| 08/15/2002 | US20020111300 Methods for reduced renal uptake of protein conjugates |
| 08/15/2002 | US20020111290 Calibration of chemokine or receptor expression; medical diagnosis |
| 08/15/2002 | US20020110871 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84 |
| 08/15/2002 | US20020110866 Nucleotide sequences coding viral capsid protein; for use in the diagnosis, treatment and/or vaccination |
| 08/15/2002 | US20020110865 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110836 PD-L2 molecules: novel PD-1 ligands and uses therefor |
| 08/15/2002 | US20020110606 Chlorogenic acid and an analog thereof for immune system stimulation |
| 08/15/2002 | US20020110569 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/15/2002 | US20020110568 Effective in eliciting the production of antibodies that recognize epitopes of native proteins |
| 08/15/2002 | US20020110567 In utero oral nucleic acid immunization |
| 08/15/2002 | US20020110566 Administering fusion protein comprising a heat shock protein (hsp) or an immunostimulatory fragment thereof, and protein of a human papilloma virus (HPV), or an antigenic fragment thereof, for therapy of wart |
| 08/15/2002 | US20020110565 Viral vectors having enhanced effectiveness with reduced virulence |
| 08/15/2002 | US20020110562 Streptococcus pneumoniae proteins and vaccines |
| 08/15/2002 | US20020110560 Lowering elevated post-prandial blood glucose levels in mammals by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity |
| 08/15/2002 | US20020110559 Confering an immune response to a tumor cell in a mammal by administering antibody which binds to aspartyl (asparaginyl) beta hydroxylase (HAAH) |
| 08/15/2002 | US20020110558 For therapy |
| 08/15/2002 | US20020110547 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/15/2002 | US20020110540 Disease prevention by reactivation of the thymus |
| 08/15/2002 | US20020110539 Modulated release particles for lung delivery |
| 08/15/2002 | US20020110538 Methods and products for tumor immunotherapy using cytokines |
| 08/15/2002 | CA2447905A1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | CA2437596A1 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | CA2437564A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/15/2002 | CA2437503A1 Hepatitis b virus treatment |
| 08/15/2002 | CA2437484A1 Ragweed allergens |
| 08/15/2002 | CA2437453A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | CA2437267A1 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | CA2437185A1 Timm8b-related protein |
| 08/15/2002 | CA2437088A1 Inactive bovine scours vaccines, processes and method of preventing bovine scours |
| 08/15/2002 | CA2436470A1 Intracellular signaling molecules |
| 08/15/2002 | CA2436435A1 Vaccine composition |
| 08/15/2002 | CA2436334A1 Adhesion molecules |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2433439A1 Proteins and nucleic acids encoding same |
| 08/14/2002 | EP1231271A2 DNA fragments of the GAG gene of Lav. |
| 08/14/2002 | EP1231262A1 Method of in vitro culture of lymphocytes and gene therapy compositions |
| 08/14/2002 | EP1230932A2 Use of antibodies for anticancer vaccination |
| 08/14/2002 | EP1230931A1 Live bacterial vaccines for allergy treatment |
| 08/14/2002 | EP1230369A2 Polypeptide hormone phosphatonin |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230364A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230356A2 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230346A2 Method for enhancing t cell reactivity toward tumour antigens |
| 08/14/2002 | EP1230270A1 Antibodies binding a non naturally occurring enantiomer (l-biotin) and their use as targeting agents |
| 08/14/2002 | EP1230268A2 Heteroclitic analogs of class i epitopes |
| 08/14/2002 | EP1230265A2 Ctage gene family |
| 08/14/2002 | EP1230264A1 Therapeutic compositions and methods for treating disease states with mutant forms of myeloid progenitor inhibitory factor-2 (mpif-2) |
| 08/14/2002 | EP1230261A2 Ny-eso-1 nonapeptide derivatives, and uses thereof |
| 08/14/2002 | EP1230257A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229936A2 Use of anti-idiotypical antibodies as vaccines against cancer |
| 08/14/2002 | EP1229935A1 Treatment of b cell malignancies using anti-cd40l antibodies in combination with anti-cd20 antibodies and/or chemotherapeutics and radiotherapy |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229933A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 08/14/2002 | EP1229932A2 Induction of mucosal immunity by vaccination via the skin route |
| 08/14/2002 | EP1229931A1 Fusion proteins of mycobacterium tuberculosis |
| 08/14/2002 | EP1229930A1 Compositions and methods for treatment of allergic disorders |
| 08/14/2002 | EP1229929A2 VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
| 08/14/2002 | EP1229925A2 Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| 08/14/2002 | EP0954329B1 Method of killing target cells in harvested cell populations with two immunotoxins |
| 08/14/2002 | EP0806964B1 Chemical compounds |
| 08/14/2002 | EP0804164B1 Method of priming an immune response in a one-day old animal |
| 08/14/2002 | EP0697876B1 Xenograft thymus |
| 08/14/2002 | EP0554389B2 Molecular clones of hiv-1 and uses thereof |
| 08/14/2002 | CN1364195A Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/14/2002 | CN1364193A BHV-1 gene-deleted virus vaccine |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364090A Medicinal compositions containing anti-Fas antibody |
| 08/14/2002 | CN1364086A Use of interleukin-18 inhibitors to inhibitor tumor metastasis |
| 08/14/2002 | CN1364084A Method of inducing cancer cell death and tumor regression |
| 08/14/2002 | CN1363682A A group of efficient expression carriers for humanized antibody of mammal cell |
| 08/14/2002 | CN1089007C Immunotherapeutic method of treating cancerous diseases by administration of gamma glubulins |
| 08/13/2002 | US6433155 Isolated cdna or rna polynucleotide comprising nucleic acid sequence encoding polypeptide comprising specified amino acid sequence, or fragment thereof |
| 08/13/2002 | US6433154 Functional receptor/kinase chimera in yeast cells |
| 08/13/2002 | US6433149 Compounds and methods for inhibiting cancer metastasis |
| 08/13/2002 | US6433148 Immunoglobulin antibodies with amino acid sequences |
| 08/13/2002 | US6433147 Immunoregulators of immune response, hybridoma, human immunoglobulin |
| 08/13/2002 | US6433143 Tie-2 ligands |
| 08/13/2002 | US6433139 Secreted protein HPEAD48 |
| 08/13/2002 | US6433138 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 08/13/2002 | US6433013 Composition comprising a carrier and a purified mycobacterial lipid cell-wall component and its use in the prevention, treatment and diagnosis of disease |
| 08/13/2002 | US6433012 Administering methyl diiodo-benzoate derivatives as angiogenesis inhibitors; reducing tumor necrosis factor; treating inflammatory bowel and crohn*s disease |
| 08/13/2002 | US6432925 RNA cancer vaccine and methods for its use |